Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas

Neurochemistry International

Volumn 55, Issue 5, 2009, Pages 307-317

  Sareddy, Gangadhara Reddy ^a   Panigrahi, Manas ^b   Challa, Sundaram ^b   Mahadevan, Anita ^b   Babu, Phanithi Prakash ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Catenin; Astrocytomas; Histological malignancy; Signaling pathway; Tumor; Wnt

Indexed keywords

BETA CATENIN; CYCLIN D1; DISHEVELLED 1; DISHEVELLED 2; DISHEVELLED 3; DISHEVELLED PROTEIN; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; PROTEIN C JUN; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

ADOLESCENT; ADULT; ASTROCYTOMA; BASE SEQUENCE; BETA CATENIN; BLOTTING, WESTERN; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; WNT PROTEINS; YOUNG ADULT;

EID: 67649365847     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.03.016     Document Type: Article

References (45)

1. Barker N., and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5 (2006) 997-1014
2. Brantjes H., Roose J., van de Wetering M., and Clevers H. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res. 29 (2001) 1410-1419
3. Brown J.D., and Moon R.T. Wnt signaling: why is everything so negative?. Curr. Opin. Cell Biol. 10 (1998) 182-187
4. Cavenee W.K. Accumulation of genetic defects during astrocytoma progression. Cancer 70 6 Suppl. (1992) 1788-1793
5. Cliffe A., Hamada F., and Beinz M. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr. Biol. 13 (2003) 960-966
6. Fogarty M.P., Kessler J.D., and Wechsler-Reya R.J. Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J. Neurobiol. 64 (2005) 458-475
7. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
8. Hayashi Y., Ueki K., Waha A., Wiestler O.D., Louis D.N., and von Deimling A. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol. 7 (1997) 871-875
9. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
10. Hecht A., Vleminckx K., Stemmler M.P., van Roy F., and Kemler R. The p300/CBP acetyl transferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 19 (2000) 1839-1850
11. Hoffmans R., Stadeli R., and Basler K. Pygopus and legless provide essential transcriptional coactivator functions to armadillo/beta-catenin. Curr. Biol. 15 (2005) 1207-1211
12. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2 (2001) 120-129
13. Howng S.L., Wu C.H., Cheng T.S., Sy W.D., Lin P.C., Wang C., and Hong Y.R. Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer Lett. 183 (2002) 95-101
14. Huang H., Mahler-Araujo B.M., Sankila A., Chimelli L., Yonekawa Y., Kleihues P., and Ohgaki H. APC mutations in sporadic medulloblastomas. Am. J. Pathol. 156 (2000) 433-437
15. Jozwiak J., Kotulska K., Grajkowska W., Jozwiak S., Zalewski W., Oldak M., Lojek M., Rainko K., Maksym R., Lazarczyk M., Skopinski P., and Wlodarski P. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas. Brain Dev. 29 (2007) 273-280
16. Kleihues P., and Cavenee W.K. Pathology and Genetics of Tumors of the Central Nervous System (World Health Organization Classification of Tumors). 2nd ed. (2000), IARC, Lyon
17. Kleihues P., and Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-Oncol. 1 (1999) 44-51
18. Kleihues P., and Ohgaki H. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 170 (2007) 1445-1453
19. Kramps T., Peter O., Brunner E., Nellen D., Froesch B., Chatterjee S., Murone M., Züllig S., and Basler K. Wnt/wingless signaling requires BCL9? legless-mediated recruitment of pygopus to the nuclear b-catenin-TCF complex. Cell 109 (2002) 47-60
20. Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., Lang F.F., McCutcheon I.E., Hassenbusch S.J., Holland E., Hess K., Michael C., Miller D., and Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 95 (2001) 190-198
21. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
22. Louis D.N. A molecular genetic model of astrocytoma histopathology. Brain Pathol. 7 (1997) 755-764
23. Moon R.T., Brown J.D., and Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13 (1997) 157-162
24. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
25. Morin P.J. Beta-catenin signaling and cancer. Bioessays 21 (1999) 1021-1030
26. Nagahata T., Shimada T., Harada A., Nagai H., Onda M., Yokoyama S., Shiba T., Jin E., Kawanami O., and Emi M. Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci. 94 (2003) 515-518
27. Okino K., Nagai H., Hatta M., Nagahata T., Yoneyama K., Ohta Y., Jin E., Kawanami O., Araki T., and Emi M. Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol. Rep. 10 (2003) 1219-1223
28. Pinson K.I., Brennan J., Monkley S., Avery B.J., and Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407 (2000) 535-538
29. Polakis P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9 (1999) 15-21
30. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
31. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
32. Robb L., and Tam P.P. Gastrula organiser and embryonic patterning in the mouse. Semin. Cell Dev. Biol. 15 (2004) 543-554
33. Sareddy, G.R., Sundaram, C., Panigrahi, M., Babu, P.P., in press. Wnt/β-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-Ethyl-N-Nitrosourea exposure. Neurochem. Res.
34. Shiina H., Igawa M., Breault J., Ribeiro-Filho L., Pookot D., Urakami S., Terashima M., Deguchi M., Yamanaka M., Shirai M., Kaneuchi M., Kane C.J., and Dahiya R. The human T-cell factor-4 gene splicing isoforms Wnt signal pathway and apoptosis in renal cell carcinoma. Clin. Cancer Res. 9 (2003) 2121-2132
35. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5522-5527
36. Simmons M.L., Lamborn K.R., Takahashi M., Chen P., Israel M.A., Berger M.S., Godfrey T., Nigro J., Prados M., Chang S., Braker F.G.2nd., and Aldape K. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 61 (2001) 1122-1128
37. Takemaru K.I., and Moon R.T. The transcriptional coactivator CBP interacts with b-catenin to activate gene expression. J. Cell Biol. 149 (2000) 249-254
38. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J.P., and He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 (2000) 530-535
39. Uematsu K., He B., You L., Xu Z., McCormick F., and Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22 (2003) 7218-7221
40. Waterman M.L. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metast. Rev. 23 (2004) 41-52
41. Wehrli M., Dougan S.T., Caldwell K., O'Keefe L., Schwartz S., Vaizel-Ohayon D., Schejter E., Tomlinson A., and DiNardo S. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407 (2000) 527-530
42. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14 (1998) 59-88
43. Yu J.M., Jun E.S., Jung J.S., Suh S.Y., Han J.Y., Kim J.Y., Kim K.W., and Jung J.S. Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett. 257 (2007) 172-181
44. Zhang Z., Schittenhelm J., Guo K., Buhring H.J., Trautmann K., Meyermann R., and Schluesener H.J. Upregulation of frizzled 9 in astrocytomas. Neuropathol. Appl. Neurobiol. 32 (2006) 615-624
45. Zorn A.M., Butler K., and Gurdon J.B. Anterior endomesoderm specification in Xenopus by Wnt/beta-catenin and TGF-beta signalling pathways. Dev. Biol. 209 (1999) 282-297